Suppr超能文献

哪些因素会增加 SARS-CoV-2 感染患者发生并发症的风险?以色列全国卫生组织的一项队列研究。

What Factors Increase the Risk of Complications in SARS-CoV-2-Infected Patients? A Cohort Study in a Nationwide Israeli Health Organization.

机构信息

KI Research Institute, Kfar Malal, Israel.

Maccabi Institute for Research and Innovation, Tel Aviv, Israel.

出版信息

JMIR Public Health Surveill. 2020 Aug 25;6(3):e20872. doi: 10.2196/20872.

Abstract

BACKGROUND

Reliably identifying patients at increased risk for coronavirus disease (COVID-19) complications could guide clinical decisions, public health policies, and preparedness efforts. Multiple studies have attempted to characterize at-risk patients, using various data sources and methodologies. Most of these studies, however, explored condition-specific patient cohorts (eg, hospitalized patients) or had limited access to patients' medical history, thus, investigating related questions and, potentially, obtaining biased results.

OBJECTIVE

This study aimed to identify factors associated with COVID-19 complications from the complete medical records of a nationally representative cohort of patients, with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

METHODS

We studied a cohort of all SARS-CoV-2-positive individuals, confirmed by polymerase chain reaction testing of either nasopharyngeal or saliva samples, in a nationwide health organization (covering 2.3 million individuals) and identified those who suffered from serious complications (ie, experienced moderate or severe symptoms of COVID-19, admitted to the intensive care unit, or died). We then compared the prevalence of pre-existing conditions, extracted from electronic health records, between complicated and noncomplicated COVID-19 patient cohorts to identify the conditions that significantly increase the risk of disease complications, in various age and sex strata.

RESULTS

Of the 4353 SARS-CoV-2-positive individuals, 173 (4%) patients suffered from COVID-19 complications (all age ≥18 years). Our analysis suggests that cardiovascular and kidney diseases, obesity, and hypertension are significant risk factors for COVID-19 complications. It also indicates that depression (eg, males ≥65 years: odds ratio [OR] 2.94, 95% CI 1.55-5.58; P=.01) as well as cognitive and neurological disorders (eg, individuals ≥65 years old: OR 2.65, 95% CI 1.69-4.17; P<.001) are significant risk factors. Smoking and presence of respiratory diseases do not significantly increase the risk of complications.

CONCLUSIONS

Our analysis agrees with previous studies on multiple risk factors, including hypertension and obesity. It also finds depression as well as cognitive and neurological disorders, but not smoking and respiratory diseases, to be significantly associated with COVID-19 complications. Adjusting existing risk definitions following these observations may improve their accuracy and impact the global pandemic containment and recovery efforts.

摘要

背景

可靠地识别出患有冠状病毒病(COVID-19)并发症风险较高的患者,有助于指导临床决策、公共卫生政策和准备工作。多项研究试图使用各种数据源和方法来描述高危患者。然而,这些研究大多都只针对特定疾病的患者队列(例如住院患者),或者只能有限地获取患者的病史,因此可能会导致研究结果出现偏差。

目的

本研究旨在从全国性的患者队列(覆盖 230 万人)的完整病历中识别出与 SARS-CoV-2 感染相关的 COVID-19 并发症的相关因素。

方法

我们研究了一个全国性卫生组织(覆盖 230 万人)中所有经聚合酶链反应检测(鼻咽拭子或唾液样本)确诊为 SARS-CoV-2 阳性的个体,确定了那些患有严重并发症(即出现中度或重度 COVID-19 症状、入住重症监护病房或死亡)的患者。然后,我们比较了复杂和非复杂 COVID-19 患者队列中从电子健康记录中提取的既往疾病的患病率,以确定在不同年龄和性别层次下显著增加疾病并发症风险的疾病。

结果

在 4353 例 SARS-CoV-2 阳性个体中,有 173 名(4%)患者患有 COVID-19 并发症(所有年龄≥18 岁)。我们的分析表明,心血管疾病和肾脏疾病、肥胖和高血压是 COVID-19 并发症的显著危险因素。同时也表明,抑郁(例如,男性≥65 岁:比值比[OR] 2.94,95%置信区间[CI] 1.55-5.58;P=.01)以及认知和神经障碍(例如,≥65 岁的个体:OR 2.65,95% CI 1.69-4.17;P<.001)也是显著的危险因素。吸烟和呼吸系统疾病的存在并不会显著增加并发症的风险。

结论

我们的分析与之前关于包括高血压和肥胖在内的多种危险因素的研究一致。同时发现抑郁以及认知和神经障碍与 COVID-19 并发症显著相关,但吸烟和呼吸系统疾病与 COVID-19 并发症不相关。根据这些观察结果调整现有的风险定义,可能会提高其准确性,并影响全球大流行的控制和恢复工作。

相似文献

4
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
5
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
J Epidemiol Glob Health. 2020 Sep;10(3):214-221. doi: 10.2991/jegh.k.200806.002.
6
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
9
Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study.
J Allergy Clin Immunol. 2020 Oct;146(4):790-798. doi: 10.1016/j.jaci.2020.08.008. Epub 2020 Aug 15.

引用本文的文献

1
The Hidden Toll of Psychological Distress in Australian Adults and Its Impact on Health-Related Quality of Life Measured as Health State Utilities.
Appl Health Econ Health Policy. 2024 Jul;22(4):583-598. doi: 10.1007/s40258-024-00879-z. Epub 2024 Mar 26.
2
COVID-19 risk, course and outcome in people with mental disorders: a systematic review and meta-analyses.
Epidemiol Psychiatr Sci. 2023 Oct 20;32:e61. doi: 10.1017/S2045796023000719.
3
Body Mass Index as a Major Prognostic Contributing Factor in COVID-19: A Multicentral Egyptian Study.
Infect Drug Resist. 2023 Sep 8;16:5985-6004. doi: 10.2147/IDR.S426440. eCollection 2023.
4
Exploring New Mechanism of Depression from the Effects of Virus on Nerve Cells.
Cells. 2023 Jul 3;12(13):1767. doi: 10.3390/cells12131767.
8
Obesity and Infection: What Have We Learned From the COVID-19 Pandemic.
Front Nutr. 2022 Jul 22;9:931313. doi: 10.3389/fnut.2022.931313. eCollection 2022.
10
Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis.
Cell Res. 2022 Oct;32(10):897-913. doi: 10.1038/s41422-022-00689-9. Epub 2022 Jul 12.

本文引用的文献

1
Collider bias undermines our understanding of COVID-19 disease risk and severity.
Nat Commun. 2020 Nov 12;11(1):5749. doi: 10.1038/s41467-020-19478-2.
2
Pre-existing traits associated with Covid-19 illness severity.
PLoS One. 2020 Jul 23;15(7):e0236240. doi: 10.1371/journal.pone.0236240. eCollection 2020.
3
Factors associated with COVID-19-related death using OpenSAFELY.
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
6
The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.
J Med Virol. 2020 Oct;92(10):1915-1921. doi: 10.1002/jmv.25889. Epub 2020 May 17.
8
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19).
Eur J Intern Med. 2020 May;75:107-108. doi: 10.1016/j.ejim.2020.03.014. Epub 2020 Mar 16.
9
A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service.
Lancet Digit Health. 2019 May 20;1(2):e63-e77. doi: 10.1016/S2589-7500(19)30012-3. eCollection 2019 Jun.
10
Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded databases.
BMC Med Res Methodol. 2019 Jun 6;19(1):115. doi: 10.1186/s12874-019-0753-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验